These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18213697)

  • 1. Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population.
    Hume GE; Fowler EV; Doecke J; Simms LA; Huang N; Palmieri O; Griffiths LR; Florin TH; Annese V; Radford-Smith GL
    Inflamm Bowel Dis; 2008 May; 14(5):585-90. PubMed ID: 18213697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
    Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
    J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
    Franchimont D; Vermeire S; El Housni H; Pierik M; Van Steen K; Gustot T; Quertinmont E; Abramowicz M; Van Gossum A; Devière J; Rutgeerts P
    Gut; 2004 Jul; 53(7):987-92. PubMed ID: 15194649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
    Brand S; Staudinger T; Schnitzler F; Pfennig S; Hofbauer K; Dambacher J; Seiderer J; Tillack C; Konrad A; Crispin A; Göke B; Lohse P; Ochsenkühn T
    Inflamm Bowel Dis; 2005 Jul; 11(7):645-52. PubMed ID: 15973118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.
    Tolentino YF; Elia PP; Fogaça HS; Carneiro AJ; Zaltman C; Moura-Neto R; Luiz RR; Carvalho Mda G; de Souza HS
    Dig Dis Sci; 2016 Sep; 61(9):2636-47. PubMed ID: 27107867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients.
    Braat H; Stokkers P; Hommes T; Cohn D; Vogels E; Pronk I; Spek A; van Kampen A; van Deventer S; Peppelenbosch M; Hommes D
    J Mol Med (Berl); 2005 Aug; 83(8):601-9. PubMed ID: 16010583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
    Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
    World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in Saudi patients with Crohn's Disease.
    Azzam N; Nounou H; Alharbi O; Aljebreen A; Shalaby M
    Int J Mol Sci; 2012; 13(4):4268-4280. PubMed ID: 22605977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistatic interaction between TLR4 and NOD2 in patients with Crohn's Disease: relation with risk and phenotype in a Spanish cohort.
    Martinez-Chamorro A; Moreno A; Gómez-García M; Cabello MJ; Martin J; Lopez-Nevot MÁ
    Immunobiology; 2016 Sep; 221(9):927-33. PubMed ID: 27290609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is age of onset of Crohn's disease governed by mutations in NOD2/caspase recruitment domains 15 and Toll-like receptor 4? Evaluation of a pediatric cohort.
    Leshinsky-Silver E; Karban A; Buzhakor E; Fridlander M; Yakir B; Eliakim R; Reif S; Shaul R; Boaz M; Lev D; Levine A
    Pediatr Res; 2005 Sep; 58(3):499-504. PubMed ID: 16148063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations.
    Lakatos PL; Lakatos L; Szalay F; Willheim-Polli C; Osterreicher C; Tulassay Z; Molnar T; Reinisch W; Papp J; Mozsik G; Ferenci P;
    World J Gastroenterol; 2005 Mar; 11(10):1489-95. PubMed ID: 15770725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype.
    Glas J; Török HP; Tonenchi L; Kapser J; Schiemann U; Müller-Myhsok B; Folwaczny M; Folwaczny C
    Inflamm Bowel Dis; 2005 Dec; 11(12):1031-7. PubMed ID: 16306764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?
    Arnott ID; Nimmo ER; Drummond HE; Fennell J; Smith BR; MacKinlay E; Morecroft J; Anderson N; Kelleher D; O'Sullivan M; McManus R; Satsangi J
    Genes Immun; 2004 Aug; 5(5):417-25. PubMed ID: 15190267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
    Abad C; González-Escribano MF; Diaz-Gallo LM; Lucena-Soto JM; Márquez JL; Leo E; Crivell C; Gómez-García M; Martín J; Núñez-Roldán A; García-Lozano JR
    Genes Immun; 2011 Dec; 12(8):635-42. PubMed ID: 21716313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.
    Lakatos PL; Altorjay I; Szamosi T; Palatka K; Vitalis Z; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Barta Z; Stocker W; Papp J; Veres G; Papp M;
    Inflamm Bowel Dis; 2009 Mar; 15(3):365-74. PubMed ID: 18972554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations.
    Schnitzler F; Friedrich M; Wolf C; Stallhofer J; Angelberger M; Diegelmann J; Olszak T; Tillack C; Beigel F; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2015; 10(7):e0116044. PubMed ID: 26147989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
    Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
    Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD2/CARD15 mutations in Polish and Bosnian populations with and without Crohn's disease: prevalence and genotype-phenotype analysis.
    Salkic NN; Adler G; Zawada I; Alibegovic E; Karakiewicz B; Kozlowska-Wiechowska A; Wasilewicz M; Sulzyc-Bielicka V; Bielicki D
    Bosn J Basic Med Sci; 2015 May; 15(2):67-72. PubMed ID: 26042516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis.
    Meena NK; Verma R; Verma N; Ahuja V; Paul J
    J Clin Gastroenterol; 2013 Oct; 47(9):773-80. PubMed ID: 23470644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.